Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Christopher D.M. Fletcher, M.D., M.B.,B.S.

Co-Author

This page shows the publications co-authored by Christopher Fletcher and Andrew Beck.
Connection Strength

0.207
  1. Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling. Oncogene. 2010 Feb 11; 29(6):845-54.
    View in: PubMed
    Score: 0.109
  2. Clinically Relevant Molecular Subtypes in Leiomyosarcoma. Clin Cancer Res. 2015 Aug 01; 21(15):3501-11.
    View in: PubMed
    Score: 0.040
  3. Expression of subtype-specific group 1 leiomyosarcoma markers in a wide variety of sarcomas by gene expression analysis and immunohistochemistry. Am J Surg Pathol. 2011 Apr; 35(4):583-9.
    View in: PubMed
    Score: 0.030
  4. Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours. J Pathol. 2010 Jan; 220(1):58-70.
    View in: PubMed
    Score: 0.028
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.